What is the main purpose of the 2018 Senior Officer PEP?

The 2018 Senior Officer PEP is designed to align executive compensation with the achievement of specific financial and quality performance targets for the fiscal year 2018. It aims to incentivize executive officers to drive both strong financial results and high standards of patient care.

How is executive compensation structured under the new program?

The program weights potential awards based on performance. Approximately 80% to 90% is tied to achieving specific EBITDA targets, while the remaining 10% to 20% is linked to meeting targets for quality of care metrics, such as infection rates, core measures, and patient experience.

What is the potential upside for executive performance under the Senior Officer PEP?

For the EBITDA-weighted portion of the award, executives can receive up to 200% of their target award for achieving maximum performance. The quality-weighted portion can also result in a full payout if target performance is met or exceeded for individual metrics, with certain adjustments based on overall company EBITDA.

Are there any conditions that could reduce or eliminate payouts?

Yes, the program includes provisions for no payments if performance falls below specified threshold amounts for both EBITDA and quality metrics. Additionally, if the company's actual EBITDA is less than 90% of the target level, there will be no payment for the quality-weighted portion. Payouts are also subject to clawback or adjustment in cases of financial restatements or misconduct.

HCA 8-K: Leadership Changes

Summary

This 8-K filing from HCA Healthcare, Inc. (HCA) on April 5, 2018, details the adoption of the 2018 Senior Officer Performance Excellence Program (Senior Officer PEP). This program outlines how the company's executive officers will be eligible to earn performance-based awards for the fiscal year 2018. The compensation structure is heavily weighted towards financial performance, specifically Earnings Before Interest, Taxes, and Depreciation and Amortization (EBITDA), with a significant portion tied to the achievement of specified EBITDA targets. The program also incorporates quality of care metrics, including Healthcare-Associated Infections, Core Measures, and Patient Experience, albeit with a smaller weighting. This dual focus indicates HCA's commitment to both financial health and high-quality patient care as key drivers for executive compensation. The filing specifies target award opportunities for named executive officers, with the CEO having the highest potential award as a percentage of base salary.

Key Highlights

1HCA Healthcare adopted the 2018 Senior Officer Performance Excellence Program (Senior Officer PEP) on March 30, 2018.
2Executive compensation is primarily linked to the achievement of specified EBITDA targets, accounting for 80-90% of potential awards.
3Quality of care metrics (Healthcare-Associated Infections, Core Measures, Patient Experience) represent 20-10% of potential awards.
4Target award opportunities for 2018 are outlined, with the CEO's target award at 170% of base salary.
5The program allows for a maximum payout of 200% of the target award for the EBITDA-weighted portion if maximum performance is achieved.
6Quality of care payouts are contingent on achieving target levels for each metric, with provisions for adjustments based on overall company EBITDA performance.
7Awards under the Senior Officer PEP will be paid solely in cash.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 5, 2018)

Summary

Key Highlights

Frequently Asked Questions